Trends and determinants of calcium antagonist usage after acute myocardial infarction (the GISSI experience)
- 15 July 1996
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 78 (2) , 153-157
- https://doi.org/10.1016/s0002-9149(96)90388-4
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- NifedipineCirculation, 1995
- Nifedipine and MortalityCirculation, 1995
- Vasodilators in Heart FailureDrugs, 1994
- Early Administration of Nifedipine in Suspected Acute Myocardial InfarctionArchives of internal medicine (1960), 1993
- Update of effects of calcium antagonists in myocardial infarction or angina in light of the second danish verapamil infarction trial (DAVIT-II) and other recent studiesThe American Journal of Cardiology, 1991
- Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II — DAVIT II)The American Journal of Cardiology, 1990
- The Effect of Diltiazem on Mortality and Reinfarction after Myocardial InfarctionNew England Journal of Medicine, 1988
- Trial of early nifedipine in acute myocardial infarction: the Trent study.BMJ, 1986
- Diltiazem and Reinfarction in Patients with Non-Q-Wave Myocardial InfarctionNew England Journal of Medicine, 1986
- Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison.Circulation, 1984